Profile
Full Name
Acelyrin, Inc.Ticker Symbol
SLRNExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 4, 2023Indexes
Not includedWebsite
http://www.acelyrin.comEmployees
83Key Details
Price
$2.23(+3.72%)
Market cap
$224.58M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$2.50(+53.96% YoY)
PE ratio
-
Next earnings date
May 13, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Acelyrin doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jan 7, 25 HC Wainwright & Co.
NeutralJan 7, 25 Citigroup
NeutralDec 11, 24 Wells Fargo
OverweightDec 11, 24 HC Wainwright & Co.
NeutralNov 14, 24 HC Wainwright & Co.
NeutralOct 16, 24 Wells Fargo
OverweightAug 19, 24 Morgan Stanley
Equal-WeightAug 15, 24 HC Wainwright & Co.
NeutralAug 14, 24 Piper Sandler
OverweightJul 8, 24 Wells Fargo
OverweightInstitutional Ownership
- What is the ticker symbol for Acelyrin?
- Does Acelyrin pay dividends?
- What sector is Acelyrin in?
- What industry is Acelyrin in?
- What country is Acelyrin based in?
- When did Acelyrin go public?
- Is Acelyrin in the S&P 500?
- Is Acelyrin in the NASDAQ 100?
- Is Acelyrin in the Dow Jones?
- When was Acelyrin's last earnings report?
- When does Acelyrin report earnings?
- Should I buy Acelyrin stock now?
What is the ticker symbol for Acelyrin?
The ticker symbol for Acelyrin is NASDAQ:SLRN
Does Acelyrin pay dividends?
No, Acelyrin does not pay dividends
What sector is Acelyrin in?
Acelyrin is in the Healthcare sector
What industry is Acelyrin in?
Acelyrin is in the Biotechnology industry
What country is Acelyrin based in?
Acelyrin is headquartered in United States
When did Acelyrin go public?
Acelyrin's initial public offering (IPO) was on May 4, 2023
Is Acelyrin in the S&P 500?
No, Acelyrin is not included in the S&P 500 index
Is Acelyrin in the NASDAQ 100?
No, Acelyrin is not included in the NASDAQ 100 index
Is Acelyrin in the Dow Jones?
No, Acelyrin is not included in the Dow Jones index
When was Acelyrin's last earnings report?
Acelyrin's most recent earnings report was on Nov 13, 2024
When does Acelyrin report earnings?
The next expected earnings date for Acelyrin is May 13, 2025
Should I buy Acelyrin stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions